Abstract
Defects in the human gene encoding methylmalonyl-CoA mutase enzyme (MCM) give rise to a rare autosomal recessive inherited disorder of propionate metabolism termed mut methylmalonic acidemia (MMA). Patients with mut MMA have been divided into two subgroups: mut0 with complete loss of MCM activity and mut- with residual activity in the presence of adenosylcobalamin (AdoCbl). The disease typically presents in the first weeks or months of life and is clinically characterized by recurrent vomiting, metabolic acidosis, hyperammonemia, lethargy, poor feeding, failure to thrive and neurological deficit. To better elucidate the spectrum of mutations causing mut MMA in Saudi patients, we screened a cohort of 60 Saudi patients affected by either forms of the disease for mutations in the MUT gene. A total of 13 different mutations, including seven previously reported missense changes and six novel mutations, were detected in a homozygous state except for two compound heterozygous cases. The six novel mutations identified herein consist of three nonsense, two missense and one frameshift, distributed throughout the whole protein. This study describes for the first time the clinical and mutational spectrum of mut MMA in Saudi Arabian patients.
Competing interests: None declared
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acquaviva C, Benoist JF, Pereira S et al (2005) Molecular basis of methylmalonyl-CoA mutase apoenzyme defect in 40 European patients affected by mut(o) and mut- forms of methylmalonic acidemia: identification of 29 novel mutations in the MUT gene. Hum Mutat 25(2):167–176
Baumgarter ER, Viardot C (1995) Long-term follow-up of 77 patients with isolated methylmalonic acidaemia. J Inherit Metab Dis 18(2):138–142
Chace DH, DiPerna JC, Kalas TA, Johnson RW, Naylor EW (2001) Rapid diagnosis of methylmalonic and propionic acidemias: quantitative tandem mass spectrometric analysis of propionylcarnitine in filter-paper blood specimens obtained from newborns. Clin Chem 47(11):2040–2044
Chandler RJ, Zerfas PM, Shanske S et al (2009) Mitochondrial dysfunction in mut methylmalonic acidemia. FASEB J 23(4):1252–1261
Coulombe JT, Shih VE, Levy HL (1981) Massachusetts metabolic disorders screening program. II. Methylmalonic aciduria. Pediatrics 67(1):26–31
Crane AM, Ledley FD (1994) Clustering of mutations in methylmalonyl CoA mutase associated with mut- methylmalonic acidemia. Am J Hum Genet 55(1):42–50
Dundar H, Ozgul RK, Guzel-Ozanturk A et al (2012) Microarray based mutational analysis of patients with methylmalonic acidemia: identification of 10 novel mutations. Mol Genet Metab 106(4):419–423
Fenton WA, Gravel RA (1995) Disorders of propionate and malonate metabolism. McGraw-Hill, New York, pp 1423–1449
Fenton WA, Hack AM, Kraus JP, Rosenberg LE (1987) Immunochemical studies of fibroblasts from patients with methylmalonyl-CoA mutase apoenzyme deficiency: detection of a mutation interfering with mitochondrial import. Proc Natl Acad Sci U S A 84(5):1421–1424
Fenton WAG, Gravel RA, Rosenblatt DS (2001) Disorders of propionate and methylmalonate metabolism. McGraw-Hill, New York, pp 2165–2193
Fowler B, Leonard JV, Baumgartner MR (2008) Causes of and diagnostic approach to methylmalonic acidurias. J Inherit Metab Dis 31(3):350–360
Froese DS, Kochan G, Muniz JR et al (2010) Structures of the human GTPase MMAA and vitamin B12-dependent methylmalonyl-CoA mutase and insight into their complex formation. J Biol Chem 285(49):38204–38213
Fuchshuber A, Mucha B, Baumgartner ER, Vollmer M, Hildebrandt F (2000) mut0 methylmalonic acidemia: eleven novel mutations of the methylmalonyl CoA mutase including a deletion-insertion mutation. Hum Mutat 16(2):179
Gradinger AB, Belair C, Worgan LC et al (2007) Atypical methylmalonic aciduria: frequency of mutations in the methylmalonyl CoA epimerase gene (MCEE). Hum Mutat 28(10):1045
Horster F, Baumgartner MR, Viardot C et al (2007) Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA, cblB). Pediatr Res 62(2):225–230
Janata J, Kogekar N, Fenton WA (1997) Expression and kinetic characterization of methylmalonyl-CoA mutase from patients with the mut-phenotype: evidence for naturally occurring interallelic complementation. Hum Mol Genet 6(9):1457–1464
Kobayashi A, Kakinuma H, Takahashi H (2006) Three novel and six common mutations in 11 patients with methylmalonic acidemia. Pediatr Int 48(1):1–4
Kovachy RJ, Copley SD, Allen RH (1983) Recognition, isolation, and characterization of rat liver D-methylmalonyl coenzyme A hydrolase. J Biol Chem 258(18):11415–11421
Ledley FD, Jansen R, Nham SU, Fenton WA, Rosenberg LE (1990) Mutation eliminating mitochondrial leader sequence of methylmalonyl-CoA mutase causes muto methylmalonic acidemia. Proc Natl Acad Sci U S A 87(8):3147–3150
Lemieux B, Auray-Blais C, Giguere R, Shapcott D, Scriver CR (1988) Newborn urine screening experience with over one million infants in the Quebec Network of Genetic Medicine. J Inherit Metab Dis 11(1):45–55
Lempp TJ, Suormala T, Siegenthaler R et al (2007) Mutation and biochemical analysis of 19 probands with mut0 and 13 with mut- methylmalonic aciduria: identification of seven novel mutations. Mol Genet Metab 90(3):284–290
Martinez MA, Rincon A, Desviat LR, Merinero B, Ugarte M, Perez B (2005) Genetic analysis of three genes causing isolated methylmalonic acidemia: identification of 21 novel allelic variants. Mol Genet Metab 84(4):317–325
Matsui SM, Mahoney MJ, Rosenberg LE (1983) The natural history of the inherited methylmalonic acidemias. N Engl J Med 308(15):857–861
Nham SU, Wilkemeyer MF, Ledley FD (1990) Structure of the human methylmalonyl-CoA mutase (MUT) locus. Genomics 8(4):710–716
Nicolaides P, Leonard J, Surtees R (1998) Neurological outcome of methylmalonic acidaemia. Arch Dis Child 78(6):508–512
Qureshi AA, Crane AM, Matiaszuk NV, Rezvani I, Ledley FD, Rosenblatt DS (1994) Cloning and expression of mutations demonstrating intragenic complementation in mut0 methylmalonic aciduria. J Clin Invest 93(4):1812–1819
Raff ML, Crane AM, Jansen R, Ledley FD, Rosenblatt DS (1991) Genetic characterization of a MUT locus mutation discriminating heterogeneity in mut0 and mut- methylmalonic aciduria by interallelic complementation. J Clin Invest 87(1):203–207
Ribas GS, Biancini GB, Mescka C et al (2012) Oxidative stress parameters in urine from patients with disorders of propionate metabolism: a beneficial effect of L:-carnitine supplementation. Cell Mol Neurobiol 32(1):77–82
Sakamoto O, Ohura T, Matsubara Y, Takayanagi M, Tsuchiya S (2007) Mutation and haplotype analyses of the MUT gene in Japanese patients with methylmalonic acidemia. J Hum Genet 52(1):48–55
Shigematsu Y, Hirano S, Hata I et al (2002) Newborn mass screening and selective screening using electrospray tandem mass spectrometry in Japan. J Chromatogr B Analyt Technol Biomed Life Sci 776(1):39–48
Sniderman LC, Lambert M, Giguere R et al (1999) Outcome of individuals with low-moderate methylmalonic aciduria detected through a neonatal screening program. J Pediatr 134(6):675–680
Thoma NH, Leadlay PF (1996) Homology modeling of human methylmalonyl-CoA mutase: a structural basis for point mutations causing methylmalonic aciduria. Protein Sci 5(9):1922–1927
Vatanavicharn N, Champattanachai V, Liammongkolkul S et al (2012) Clinical and molecular findings in Thai patients with isolated methylmalonic acidemia. Mol Genet Metab 106(4):424–429
Willard HF, Rosenberg LE (1980) Inherited methylmalonyl CoA mutase apoenzyme deficiency in human fibroblasts: evidence for allelic heterogeneity, genetic compounds, and codominant expression. J Clin Invest 65(3):690–698
Worgan LC, Niles K, Tirone JC et al (2006) Spectrum of mutations in mut methylmalonic acidemia and identification of a common Hispanic mutation and haplotype. Hum Mutat 27(1):31–43
Acknowledgements
The authors would like to thank the patients and their families for participating in this study and the KFSH&RC Department of Genetics Sequencing Core Facility. This work was funded by the King Faisal Specialist Hospital and Research Centre (RAC# 2020 011).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Ivo Barić, M.D., PhD, Professor of Pediatrics
Compliance with Ethics Guidelines
Compliance with Ethics Guidelines
Informed Consent: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients being included in the study.
FI, BAM, AM, MH and RA performed molecular genetic studies, analysis and interpretation. ZH, MO, HZ, ZR, AQ, EF, AA, FM, MF, WE, MS and MAS provided patient information, clinical diagnosis and samples and were involved in data interpretation. All authors were all involved in drafting and revising the article.
Rights and permissions
Copyright information
© 2014 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Imtiaz, F. et al. (2014). Spectrum of Mutations in 60 Saudi Patients with Mut Methylmalonic Acidemia. In: Morava, E., Baumgartner, M., Patterson, M., Rahman, S., Zschocke, J., Peters, V. (eds) JIMD Reports, Volume 29. JIMD Reports, vol 29. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2014_297
Download citation
DOI: https://doi.org/10.1007/8904_2014_297
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-53277-5
Online ISBN: 978-3-662-53278-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)